The immune system plays a crucial role in fighting cancer. Our research focuses on training dendritic cells to trigger an active immune response, targeting tumors like melanoma, renal cell carcinoma, and glioblastoma. Clinical trials show promising results—bringing us closer to a breakthrough. Unlike traditional treatments, our approach is personalized, targeted, and immune-driven. We train immune cells to recognize and attack cancer—turning the body into its own best defense.